Health-Related Quality Of Life In Patients With Metastatic Merkel Cell Carcinoma Receiving Second-Line Or Later Avelumab Treatment: 36-Month Follow-Up DataS. P. D'Angelo,S. Nolte,M. Schlichting, M. Henry-Szatkowski,M. Hennessy,M. BharmalANNALS OF ONCOLOGY（2019）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
